In spite of their unusual molecular structures and seemingly high degree of biological recalcitrance, many antibiotics have been shown to be susceptible to microbial attack. Among the types of changes brought about by microbial systems are: (i) acylation; (ii) phosphorylation; (iii) adenylylation and ribonucleotide ·rormation; (iv) hydrolysis; (v) oxidation; (vi) sulphoxidation; (vii) reduction; (viii) demethylation; and (ix) deamination.
I. INTRODUCTION
Although more than thirty years have passed since the first reports of the therapeutic promise of penicillin, and the description of a microbiological transformation of this antibiotic\ only a limited effort has been invested in using enzymes to produce new and potentially useful antibiotic derivatives. The success of the chemical modification programmes with a number of clinically important antibiotics including penicillin 2 , cephalosporin 3 , tetracycline4, lincomycin 5 , and rifamycin 6 , encouraged large-scale efforts to modify coumermycin Ai, kasugamycin 8 and mitomycin 9 • It is one of the purposes of this review to summarize the information on microbiological transformation of antibiotics and to suggest some possible applications of this knowledge.
A brief survey of the Iiterature shows that there are numerous reports on complete loss of antimicrobial activity when actinomycin, chloramphenicol, chlortetracycline, cycloheximide, griseofulvin, mycophenolic acid, oxytetracycline, patulin, penicillin and streptomycin were added to different types of Some of the antibiotics reported to undergo these transformations are listed in Table 1 . The structures of some of these antibiotics, the types of transformations, and the structures of some of the products are shown in Figur es 1 to 6. In addition, there are reports of non-specific degradations of antibiotics:
Several antibiotics have been shown to serve as the only source of C, N and energy for bacterial growth~ or to serve as growth factors for antibioticdependent bacteria. Streptomycin, a growth substance for certain pseudomonads80, is decomposed by several pathways depending on the culture used 81 · 82 , with urea and streptamine as intermediates.
In a study with a neamine-dependent Staphylococcus aureus it was found that those antibiotics containing amino-hexoses and NHrgroups at C-2 of the hexose, e.g. streptomycin, paromomycin, zygomycin and neomycin C, could substitute for neamine, while those with an NH 2 -group at C-3, e.g. kanamycin, erythromycin, or no amino-hexoses, e.g. spectinomycin, vancomycin, did not support growth of the coccus 83 . Similar results were obtained with streptomycin-dependent Staphylococcus aureus and Salmonella paratyphi B but not with streptomycin-dependent strains of Escherichia coli and Mycobacteria 83 . The components of the streptomycin molecule as well as streptomycin derivatives were also able to substitute for growth of streptomycin-and neomycin-dependent mutants of Escherichia coli 84 . These and other reports 85 aresuggestive of antibiotic modification but do not identify the changes in chemical or enzymatic terms.
Similar studies with tetracyclines showed Xylaria species capable of inactivating the antibiotics 86 , but the chemistry of the degradation products was not reported.
II. TECHNIQUES USEFUL IN STUDYING MICROBIAL TRANSFORMATIONS OF ANTIBIOTICS
Review of the reports on microbial transformations of a number of antibiotics shows that selection of the microorganism depends in part on the background of the investigator. The bioehernist and ehernist have usually been confident of the value of testing pure cultures obtained from recognized culture collections, while the mic!'obiologist has often utilized the classical enrichment techniques 87 · 88 so helpful in isolating microorganisms with unusual enzymatic abilities.
Other factors, however, must be considered before more definitive conclusions are drawn. Some antibiotics, especially albidin, frequentin, gliotoxin, penicillin and viridin, have been inactivated due to instability of the natural pH of the soil. Others, including streptomycin and tetracyclines, were inactivated by absorption on clay minerals or organic matter of the soil 11 . Only griseofulvin, mycophenolic acid and patulin appear to be biologically degraded in soil 10 · 89 .
Since antibiotics may serve as both providing C, N and energy for growth, and also interfering with the life processes of the cells themselves, enrichment of the 'open' type is sometimes preferred. Under these conditions noninhibitory constant antibiotic concentrations are maintained while the metabolic products are continuously removed.
In many studies more or less randomly chosen microorganisms have been grown in complex media to promote rapid and heavy cell growth. Since nearly all antibiotic-producing microorganisms have the ability to produce families of closely related antibiotics, it has usually been profitable to search among these organisms for enzymatic ability to transform given antibiotics. Phosphorylation of streptomycin 90 • 91 , phosphorylation of neomycin 92 , acylation of spiramycin 67 and hydrolysis of mannosidostreptomycin52· 53 are among the transformations carried out by the antibioticproducing cultures.
It is common experience that even a very minor chemical change in an antibiotic molecule results in a drastic decrease or complete loss of antimicrobial activity. Only rarely there is an increase in biopotency. Hence a convenient method to detect changes due to microbial action is to monitor the bioactivity by a microorganism sensitive to the substrate antibiotic. However, since there is a possibility that bioactive products may also be formed, the traditional agar diffusion disc-plate assay method should be supplemented with chromatography on paper or thin-layer. Use of the Iatter results in separation and purification of the metabolic products for further testing and study. If it is possible to obtain the substrate antibiotic in radioactively Iabelied form (both 14 C and 3 H have been used), much time and effort can be saved by locating radioactive areas on the chromatogram. Once isolated and purified, the radioactive compound may be identified and characterized by conventional chemical and physical methods.
Inactivation of the aminoglycoside antibiotics, e.g. streptomycin, kanamycin, etc., by cell-free preparations oftheR factor-carrying bacteria, has led to the expected conclusion that several closely related enzymes obtained from different organisms carry out the same type of transformation. Each has some substrate specificity and it is possible by genetic techniques to obtain mutants more suitable for the intended study (higher Ievels of the desired enzyme or its absence). Although the possibility of finding enzymes transforming various antibiotics among the microorganisms resistant to the antibiotic is attractive, studies have shown that the in vivo resistance to an antibiotic is due to the lack of its absorption or serum binding in the body rather than to the enzymatically catalysed alterations of its molecules. Table 1 have been carried out with growing cultures or resting cells of microorganisms selected in different ways. In the case ofmycophenolic acid transformations 55 , hundreds of organisms have been examined for the ability to carry out changes of the molecule, and approximately ten per cent of them have had this ability. In many instances the enzymes carrying out the transformations have been shown tobe inducible (rather than constitutive) and at least a portion of the antibiotic molecule was required tobe present in the growth medium before the degrading enzymes were detected in the cells.
TRANSFORMATIONS OF ANTIBIOTICS BY PURIFIED ENZYMES Practically all of the transformations listed in
Isolation and purification of the enzymes involved in the transformations has been infrequently attempted. Some of the data reported are summarized in Table 2 . The ß-lactamases have been crystallized 93 and a few of the other enzymes have been purified more than 100-fold. One might expect that attempts would be made to purify those enzymes involved in a transformation where the product of the enzyme catalysed reaction had economic value. However, this does not seem tobe the case, as far as it can be determined from the Iiterature on penicillin acylase, mannosidostreptomycinase and the acylases attacking the macrolide antibiotics. With the advent of the fixedbed enzyme technology, it should be feasible to attach the enzyme to an inert support and to use it for large-scale transformation of the antibiotic in question. Under these circumstances the increased use of the enzyme would probably be more than equal to the effort needed to release it from the microbial cells and to purify.
IV. SUMMARY AND PROSPECT FOR THE FUTURE
The studies published to date indicate that all antibiotics can be expected to undergo microbial attack. In some instances, the attack has resulted in rather complete degradation of the molecule; and in other instances the changes have been limited to hydrolysis oxidation, reduction, deamination, demethylation, acylation, phosphorylation or adenylylation. Some of these latter transformations are difficult to carry out by chemical means, and their utility should lead to further studies.
The diversity of enzyme attack on antibiotic structures should encourage further exploration. It took some ten years of study of microbial transformation of steroids (and survey of over 10000 organisms) to realize the Iimitations and advantages of this method for the production of new compounds. It should not be expected that antibiotic transformation will require less effort for similar returns. ·
